Table Info

Direct effect on the cardiovascular system	Indirect effect on the cardiovascular system
- Myocarditis	- Venous thromboembolism
- Acute coronary syndrome	- Pulmonary embolism
- Heart failure
- Arrhythmia
- Cardiogenic shock

Declarations

Acknowledgments

The authors thank the medical staff of the Cheikh Khalifa hospital as well as the patient who participated in this study.

Author contributions

SM, YZ and YT : Conceptualization. AL, MM, MC, ZH, MA, CE, HB and YT: Investigation, Validation. YZ and YT: Supervision, Writing—original draft, Writing—review & editing. All authors read and approved the submitted version.

Conflicts of interest

The authors declare no competing financial interests.

Ethical approval

The recruitment of patients was approved by the Ethics Committee of Cheikh Khalifa Hospital (CEFCK/PR/2021/PR02) and complies with the Declaration of Helsinki.

Consent to participate

All participants gave their written informed consent.

Consent to publication

The patient has given consent for images or other clinical information relating to his case to be reported in a medical publication.

Availability of data and materials

Not applicable.

Funding

Not applicable.

Copyright

References

Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol. 2020;75:2352–71. [DOI] [PubMed] [PMC]

Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin-angiotensin-aldosterone system inhibitors in patients with COVID-19. N Engl J Med. 2020;382:1653–9. [DOI] [PubMed] [PMC]

Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong JC, Turner AJ, et al. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ Res. 2020;126:1456–74. [DOI] [PubMed] [PMC]

Boisramé-Helms J, Kremer H, Schini-Kerth V, Meziani F. Endothelial dysfunction in sepsis. Curr Vasc Pharmacol. 2013;11:150–60. [DOI] [PubMed]

Libby P, Loscalzo J, Ridker PM, Farkouh ME, Hsue PY, Fuster V, et al. Inflammation, immunity, and infection in atherothrombosis: JACC review topic of the week. J Am Coll Cardiol. 2018;72:2071–81. [DOI] [PubMed] [PMC]

The Lancet Planetary Health. Post-COVID-19 spending. Lancet Planet Health. 2020;4:e168. [DOI] [PubMed]

Lai CC, Wang CY, Wang YH, Hsueh SC, Ko WC, Hsueh PR. Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status. Int J Antimicrob Agents. 2020;55:105946. [DOI] [PubMed] [PMC]

Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med. 2020;382:e38. [DOI] [PubMed] [PMC]

Poissy J, Goutay J, Caplan M, Parmentier E, Duburcq T, Lassalle F, et al. Pulmonary embolism in patients with COVID-19: awareness of an increased prevalence. Circulation. 2020;142:184–6. [DOI] [PubMed]

10.

Gabrielli M, Lamendola P, Esperide A, Valletta F, Franceschi F. COVID-19 and thrombotic complications: pulmonary thrombosis rather than embolism? Thromb Res. 2020;193:98. [DOI] [PubMed] [PMC]

11.

Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26:517–38. Erratum in: J Vasc Surg. 2001;33:805. [DOI] [PubMed]

12.

Weaver ML, Hicks CW, Canner JK, Sherman RL, Hines KF, Mathioudakis N, et al. The society for vascular surgery wound, ischemia, and foot infection (WIfI) classification system predicts wound healing better than direct angiosome perfusion in diabetic foot wounds. J Vasc Surg. 2018;68:1473–81. [DOI] [PubMed]

13.

Ganatra S, Dani SS, Shah S, Asnani A, Neilan TG, Lenihan D, et al. Management of cardiovascular disease during coronavirus disease (COVID-19) pandemic. Trends Cardiovasc Med. 2020;30:315–25. [DOI] [PubMed] [PMC]

14.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–62. Erratum in: Lancet. 2020;395:1038. [DOI] [PubMed] [PMC]

15.

Heffernan DS, Evans HL, Huston JM, Claridge JA, Blake DP, May AK, et al. Surgical infection society guidance for operative and peri-operative care of adult patients infected by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Surg Infect (Larchmt). 2020;21:301–8. [DOI] [PubMed]

16.

Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–80.e8. [DOI] [PubMed] [PMC]

17.

Deng SQ, Peng HJ. Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China. J Clin Med. 2020;9:575. [DOI] [PubMed] [PMC]

18.

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al.; China Medical Treatment Expert Group for COVID-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–20. [DOI]

19.

Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844–7. [DOI] [PubMed] [PMC]

20.

Zaid Y, Puhm F, Allaeys I, Naya A, Oudghiri M, Khalki L, et al. Platelets can associate with SARS-CoV-2 RNA and are hyperactivated in COVID-19. Circ Res. 2020;127:1404–18. [DOI] [PubMed] [PMC]

21.

Zaid Y, Doré É, Dubuc I, Archambault AS, Flamand O, Laviolette M, et al. Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19. J Allergy Clin Immunol. 2021;148:368–80.e3. [DOI] [PubMed] [PMC]

22.

Archambault AS, Zaid Y, Rakotoarivelo V, Turcotte C, Doré É, Dubuc I, et al. High levels of eicosanoids and docosanoids in the lungs of intubated COVID-19 patients. FASEB J. 2021;35:e21666. [DOI] [PubMed] [PMC]

23.

Borrelli MP, Buora A, Scrivere P, Sponza M, Frigatti P. Arterial thrombotic sequalae after COVID-19: mind the gap. Ann Vasc Surg. 2021;75:128–35. [DOI] [PubMed] [PMC]

24.

Mustapha JA, Anose BM, Martinsen BJ, Pliagas G, Ricotta J, Boyes CW, et al. Lower extremity revascularization via endovascular and surgical approaches: a systematic review with emphasis on combined inflow and outflow revascularization. SAGE Open Med. 2020;8:2050312120929239. [DOI] [PubMed] [PMC]

25.

Valdivia AR, Sanus ÉA, Santos ÁD, Olmos CG, Alguacil SG, Amrani MÉ, et al. Adapting vascular surgery practice to the current COVID-19 era at a tertiary academic center in Madrid. Ann Vasc Surg. 2020;67:1–5. [DOI] [PubMed] [PMC]

26.

Vascular and Endovascular Research Network (VERN) COVER study collaborative*. Global impact of the first coronavirus disease 2019 (COVID-19) pandemic wave on vascular services. Br J Surg. 2020;107:1396–400. [DOI] [PubMed] [PMC]

27.

Al-Samkari H, Karp Leaf RS, Dzik WH, Carlson JCT, Fogerty AE, Waheed A, et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020;136:489–500. [DOI] [PubMed] [PMC]

28.

Mei F, Fan J, Yuan J, Liang Z, Wang K, Sun J, et al. Comparison of venous thromboembolism risks between COVID-19 pneumonia and community-acquired pneumonia patients. Arterioscler Thromb Vasc Biol. 2020;40:2332–7. [DOI] [PubMed] [PMC]

29.

Bilaloglu S, Aphinyanaphongs Y, Jones S, Iturrate E, Hochman J, Berger JS. Thrombosis in hospitalized patients with COVID-19 in a New York City Health System. JAMA. 2020;324:799–801. [DOI] [PubMed] [PMC]

30.

Cattaneo M, Bertinato EM, Birocchi S, Brizio C, Malavolta D, Manzoni M, et al. Pulmonary embolism or pulmonary thrombosis in COVID-19? Is the recommendation to use high-dose heparin for thromboprophylaxis justified? Thromb Haemost. 2020;120:1230–2. [DOI] [PubMed] [PMC]

31.

Maatman TK, Jalali F, Feizpour C, Douglas A 2nd, McGuire SP, Kinnaman G, et al. Routine venous thromboembolism prophylaxis may be inadequate in the hypercoagulable state of severe coronavirus disease 2019. Crit Care Med. 2020;48:e783–90. [DOI] [PubMed] [PMC]

32.

Rapkiewicz AV, Mai X, Carsons SE, Pittaluga S, Kleiner DE, Berger JS, et al. Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: a case series. EClinicalMedicine. 2020;24:100434. [DOI] [PubMed] [PMC]

33.

Puhm F, Allaeys I, Lacasse E, Dubuc I, Galipeau Y, Zaid Y, et al. Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cells. Blood Adv. 2022;6:3593–605. [DOI] [PubMed] [PMC]

34.

Horowitz JM, Yuriditsky E, Henderson IJ, Stachel MW, Kwok B, Saric M. Clot in transit on transesophageal echocardiography in a prone patient with COVID-19 acute respiratory distress syndrome. CASE (Phila). 2020;4:200–3. [DOI] [PubMed] [PMC]

35.

Anthi A, Konstantonis D, Theodorakopoulou M, Apostolopoulou O, Karampela I, Konstantopoulou G, et al. A severe COVID-19 case complicated by right atrium thrombus. Am J Case Rep. 2020;21:e926915. [DOI] [PubMed] [PMC]

36.

Sperotto F, Friedman KG, Son MBF, VanderPluym CJ, Newburger JW, Dionne A. Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach. Eur J Pediatr. 2021;180:307–22. [DOI] [PubMed] [PMC]

37.

Leon MPD, Redzepi A, McGrath E, Abdel-Haq N, Shawaqfeh A, Sethuraman U, et al. COVID-19-associated pediatric multisystem inflammatory syndrome. J Pediatric Infect Dis Soc. 2020;9:407–8. [DOI] [PubMed] [PMC]

38.

Dionne A, Mah DY, Son MBF, Lee PY, Henderson L, Baker AL, et al. Atrioventricular block in children with multisystem inflammatory syndrome. Pediatrics. 2020;146:e2020009704. [DOI] [PubMed]

39.

Singh JM, Palting RL, Bratincsak A. Junctional tachycardia due to multisystem inflammatory syndrome in children with SARS-CoV-2 infection in a 12-year-old female. Cardiol Young. 2021;31:1021–3. [DOI] [PubMed] [PMC]

40.

Frank DB, Patel AR, Sanchez GR, Shah MJ, Bonney WJ. Junctional tachycardia in a child with Lyme carditis. Pediatr Cardiol. 2011;32:689–91. [DOI] [PubMed]